Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions
Won Young Tak(Kyungpook National University Hospital), Riccardo Lencioni(University of Pisa), Masao Omata(University of Yamanashi Hospital), Stephen N. Wong(Philippine General Hospital), Minhua Chen(Lishui City People's Hospital), Jiasheng Zheng(Beijing YouAn Hospital), June Sung Lee, Basri Johan Jeet Abdullah(University Malaya Medical Centre), Morris Sherman(University Health Network), Lukas Makris(DM-STAT (United States)), Cheng‐Yuan Peng(China Medical University), Richard S. Finn(University of California, Los Angeles), Julieta Gopez-Cervantes(St. Luke's Medical Center), Yi‐You Chiou(Taipei Veterans General Hospital), Jae Young Lee(Chungnam National University), Soo Young Park(Kyungpook National University Hospital), Yijun Wang(Wuhan University), Shi-Ming Lin(Chang Gung Memorial Hospital), Jongyoung Choi(Catholic University of Korea), Ronnie T.P. Poon(University of Hong Kong), Michael O’Neal(Campbellsville University), Ruocai Xu(Hunan Cancer Hospital), Guan‐Tarn Huang(National Taiwan University Hospital), Jianqiang Cai(Chinese Academy of Medical Sciences & Peking Union Medical College), Nicholas Borys(Celsion (United States))
Cited by 166
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k